Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.05M | $27.5M | $955K | $814K | $853K | $201M | $53.9M | $91.4M | $135M | $9.68M |
| Revenue growth | — | 2508.4% | -96.5% | -14.8% | 4.8% | 23414.3% | -73.1% | 69.5% | 47.9% | -92.8% |
| Operating income | -$160M | -$155M | -$159M | -$85.7M | -$113M | $72.0M | -$132M | -$191M | -$155M | -$215M |
| Operating margin | -15121.8% | -564.2% | -16634.0% | -10527.9% | -13216.2% | 35.9% | -244.1% | -209.1% | -114.4% | -2216.4% |
| Net income | -$160M | -$153M | -$156M | -$77.7M | -$111M | $67.0M | -$117M | -$147M | -$122M | -$244M |
| Net margin | -15176.1% | -556.8% | -16297.9% | -9542.6% | -13029.8% | 33.4% | -217.0% | -160.9% | -90.5% | -2520.6% |
| EPS (diluted) | -$4.66 | -$4.07 | -$3.93 | -$1.95 | -$2.78 | $1.38 | -$2.47 | -$2.76 | -$2.27 | -$4.53 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$116M | -$131M | -$28.3M | -$53.0M | -$80.4M | $92.6M | -$109M | -$134M | -$150M | -$164M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $387M | $418M | $428M | $376M | $295M | $579M | $710M | $619M | $471M | $308M |
| Total assets | $460M | $496M | $499M | $419M | $333M | $609M | $758M | $696M | $547M | $327M |
| Total liabilities | $94.6M | $89.1M | $176M | $146M | $149M | $143M | $136M | $135M | $60.2M | $46.3M |
| Shareholders' equity | $365M | $407M | $323M | $273M | $184M | $466M | $622M | $561M | $487M | $280M |
| Retained earnings | -$289M | -$442M | -$598M | -$672M | -$783M | -$716M | -$833M | -$980M | -$1.10B | -$1.35B |
| Shares (wtd avg diluted) | 34.8M | 38.5M | 39.9M | 39.9M | 39.9M | 48.5M | 47.4M | 53.2M | 53.8M | 53.8M |
Every figure is extracted from PROTHENA CORP PUBLIC LTD CO’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.